Wealthy Way The Truth About Peptides Doctors Won’t Tell You
9 snips
Apr 23, 2026 Sam Tejada, longevity expert and founder of IV clinics and an IV therapy company, breaks down peptides, diagnostics, IV therapeutics, and precision longevity practices. He contrasts new GLP drugs with older options. He explains safety, personalized protocols, DEXA scans, heart screening, mitochondrial support, and practical daily habits for lasting health.
AI Snips
Chapters
Transcript
Episode notes
Why Peptides Suddenly Blew Up
- Peptides exploded because FDA limits on compounded peptides pushed public interest and online sellers into the open market.
- Sam notes influencers and atypical sellers flooded awareness after regulatory shifts, accelerating mainstream demand.
Why New GLP Drugs Outperform Older Ones
- New multi-receptor drugs (tirzepatide/retatrutide) give bigger fat loss with fewer nausea issues than early GLP-1s.
- Sam cites roughly 20–25% fat loss on RETA versus 10–15% on older GLP-1s.
Get Scans And Bloodwork Before Peptides
- Do medical supervision and diagnostics before starting GLP-1 or other peptides.
- Sam recommends blood work and body composition (DEXA) to avoid muscle loss and track visceral fat changes.